| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971474 | The Journal of Heart and Lung Transplantation | 2010 | 7 Pages |
Abstract
HRQoL after HTx is relatively good and comparable to the age- and gender-matched reference population. HRQoL is vulnerable to side-effects caused by the obligatory post-HTx immunosuppressive regimen, where GI symptoms play a major but clearly an underestimated role.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Janne J. MD, PhD, Pekka MD, PhD, Karl B. MD, PhD, Jyri MD, PhD, Jorma MD, PhD, Ari L.J. MD, PhD,